Zamora, Marven S.
HRN: 24-12-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2023
CEFUROXIME 500MG (TAB)
11/20/2023
11/27/2023
ORAL
500mg
Every 12hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes